Concord Biotech reports marginal decline in Q3 consolidated net profit

14 Feb 2025 Evaluate

Concord Biotech has reported results for third quarter ended December 31, 2024 (Q3FY25). 

The company has reported marginal decline of 0.62% in its net profit at Rs 74.09 crore for Q3FY25 as compared to Rs 74.55 crore for the same quarter in the previous year. However, total income of the company increased marginally by 4% at Rs 258.95 crore for Q3FY25 as compared to Rs 248.98 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported marginal decline of 2.13% in its net profit at Rs 75.92 crore for the quarter ended December 31, 2024 as compared to Rs 77.57 crore for the same quarter in the previous year. However, total income of the company increased marginally by 4% at Rs 258.95 crore for Q3FY25 as compared to Rs 248.98 crore for the corresponding quarter previous year.


Concord Biotech Share Price

1556.15 -32.95 (-2.07%)
28-Apr-2025 14:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1833.00
Dr. Reddys Lab 1194.05
Cipla 1556.35
Lupin 2098.10
Zydus Lifesciences 885.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...